#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12788	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2390	660.7	0	.	n	.	0	A69G	SNP	69	69	A	468	468	G	845	G	844	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12788	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2390	660.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1849	1849	T	865	T,A,G	861,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12788	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2390	660.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1583	1583	C	859	C	859	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21852	23S	2890	2890	99.93	23S.l15.c30.ctg.1	4098	666.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1960	1960	A	933	A	933	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21852	23S	2890	2890	99.93	23S.l15.c30.ctg.1	4098	666.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2594	2594	C	767	C,T	765,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21852	23S	2890	2890	99.93	23S.l15.c30.ctg.1	4098	666.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2668	2668	A	773	A	773	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21852	23S	2890	2890	99.93	23S.l15.c30.ctg.1	4098	666.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3220	3220	C	737	C,G	736,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	1850	folP	852	852	99.88	folP.l15.c4.ctg.1	1880	122.8	0	.	p	.	0	E151K	NONSYN	451	453	GAA	935	937	AAA	176;170;170	A;A;A	176;170;170	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	1850	folP	852	852	99.88	folP.l15.c4.ctg.1	1880	122.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1166	1168	AGC	195;194;195	A;G;C	195;194;195	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4560	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3806	149.6	1	SNP	p	S91F	0	.	.	271	273	TCC	794	796	TCC	182;179;180	T;C;C	182;179;180	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4560	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3806	149.6	1	SNP	p	D95G	0	.	.	283	285	GAC	806	808	GAC	188;188;187	G;A;C	188;188;187	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4560	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3806	149.6	1	SNP	p	D95N	0	.	.	283	285	GAC	806	808	GAC	188;188;187	G;A;C	188;188;187	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1914	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1706	140.1	1	SNP	p	G45D	0	.	.	133	135	GGC	683	685	GGC	242;244;245	G;G;C	242;244;245	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1004	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1548	80.8	0	.	n	.	0	A197.	DEL	197	197	A	765	765	A	216	A	216	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3456	154.9	1	SNP	p	D86N	0	.	.	256	258	GAC	888	890	GAC	182;184;183	G;A;C	182;184;183	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3456	154.9	1	SNP	p	S87W	0	.	.	259	261	AGT	891	893	AGT	181;183;184	A;G,C;T,A	181;182,1;183,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3456	154.9	1	SNP	p	S87I	0	.	.	259	261	AGT	891	893	AGT	181;183;184	A;G,C;T,A	181;182,1;183,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3456	154.9	1	SNP	p	S87R	0	.	.	259	261	AGT	891	893	AGT	181;183;184	A;G,C;T,A	181;182,1;183,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3456	154.9	1	SNP	p	S88P	0	.	.	262	264	TCC	894	896	TCC	188;188;189	T;C;C,A	188;188;188,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3818	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3070	155.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1750	1752	GGC	243;241;235	G;G;C	243;241;235	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1444	1446	GCA	221;222;220	G;C;A	221;222;220	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1447	1449	ATC	222;222;223	A;T,G;C,G,A	222;221,1;221,1,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1459	1461	GTG	215;214;212	G;T;G	215;214;212	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1459	1461	GTG	215;214;212	G;T;G	215;214;212	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1963	1965	ACC	193;190;191	A;C,A;C	193;189,1;191	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2017	2019	GCG	194;193;193	G;C;G,C	194;193;192,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2017	2019	GCG	194;193;193	G;C;G,C	194;193;192,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2140	2142	GGC	195;194;197	G;G,A;C	195;193,1;197	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2149	2151	GGC	202;198;196	G;G;C,A	202;198;195,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3590	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2868	156.1	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2167	2169	CTG	203;203;202	C;T,G;G,A	203;201,2;201,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4906	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3434	178.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1780	1782	CCG	199;199;200	C,G;C,T;G	198,1;198,1;200	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2092	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2153	121.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	742	742	C	150	C	150	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	248	porB1a	984	99	93.94	porB1a.l15.c17.ctg.2	179	42.5	0	.	p	.	0	M18T	NONSYN	52	54	ATG	132	134	ACG	51;50;49	A,C;C,T;G	50,1;49,1;49	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	248	porB1a	984	99	93.94	porB1a.l15.c17.ctg.2	179	42.5	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	174	176	CAA	13;13;12	C;A;A	13;13;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	248	porB1a	984	145	92.41	porB1a.l15.c17.ctg.3	145	45.2	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	29;30;33	T;T;A	29;30;33	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	248	porB1a	984	145	92.41	porB1a.l15.c17.ctg.3	145	45.2	0	.	p	.	0	S271T	NONSYN	811	813	TCG	53	55	ACT	53;53;53	A;C;T	53;53;53	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	248	porB1a	984	145	92.41	porB1a.l15.c17.ctg.3	145	45.2	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	53;53;53	C;A;T	53;53;53	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	248	porB1a	984	145	92.41	porB1a.l15.c17.ctg.3	145	45.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	53;53;53	A;G;T	53;53;53	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	248	porB1a	984	145	92.41	porB1a.l15.c17.ctg.3	145	45.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	53;53;53	T;A;C	53;53;53	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1963	160.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	585	587	GAA	205;206;205	G,C;A;A	204,1;205;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1963	160.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	873	875	GAT	225;225;224	G,T;A;T	224,1;225;224	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1963	160.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	996	998	TCA	223;222;223	T;C,G,T;A,G	223;218,3,1;222,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1963	160.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1125	1127	GTC	226;224;220	G;TCCCC,TCCC;C	226;211,1;220	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1963	160.0	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1347	1349	ACT	220;220;216	A;C;T	220;220;216	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1963	160.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1455	1457	GCA	213;215;215	G;C;A	213;215;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1963	160.0	1	SNP	p	G120K	1	.	.	358	360	AAG	831	833	AAG	224;223;224	A;A;G	224;222;224	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1963	160.0	1	SNP	p	A121D	1	.	.	361	363	GAC	834	836	GAC	224;227;228	G;A;C	224;227;228	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2528	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1963	160.0	1	SNP	p	D121N	0	.	.	361	363	GAC	834	836	GAC	224;227;228	G;A;C	224;227;228	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8760	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	5283	206.9	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2115	2117	AAT	238;242;239	A;A;T	238;242;239	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1284	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1456	109.5	1	SNP	p	V57M	1	.	.	169	171	ATG	756	758	ATG	256;256;252	A;T,C;G,C	256;255,1;251,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
